Bausch Health Companies Inc (BHC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,075,000 | 2,819,000 | 2,858,000 | 2,866,000 | 2,627,500 |
| Income taxes - deferred | -230,000 | -144,000 | -4,386,000 | -236,000 | -7,000 |
| Accounts receivable | 39,000 | 216,000 | 417,000 | -34,000 | -625,900 |
| Accounts payable and accrued liabilities | N/A | -121,000 | 387,000 | -144,000 | 170,300 |
| Other Working Capital | -318,000 | 18,000 | 844,000 | -110,000 | -822,200 |
| Other Operating Activity | -65,000 | -1,287,000 | 2,170,000 | -255,000 | 857,700 |
| Operating Cash Flow | $1,501,000 | $1,501,000 | $2,290,000 | $2,087,000 | $2,200,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -270,000 | -157,000 | -171,000 | -235,000 | -235,200 |
| Net Acquisitions | -180,000 | 5,000 | 0 | -49,000 | -15,457,400 |
| Purchase Of Investment | -16,000 | -7,000 | -7,000 | -1,000 | -49,300 |
| Sale Of Investment | 10,000 | 7,000 | 2,000 | 17,000 | 251,300 |
| Purchase Sale Intangibles | -8,000 | -78,000 | -165,000 | -56,000 | -68,100 |
| Other Investing Activity | 45,000 | 34,000 | 3,228,000 | 199,000 | -18,700 |
| Investing Cash Flow | $-419,000 | $-196,000 | $2,887,000 | $-125,000 | $-15,577,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | -3,000 | -7,000 | 0 | -300 |
| Debt Issued | 5,960,000 | 8,944,000 | 9,424,000 | 1,220,000 | 17,817,400 |
| Debt Repayment | -4,406,000 | -10,101,000 | -14,203,000 | -2,436,000 | -5,177,900 |
| Common Stock Issued | N/A | N/A | 0 | 0 | 1,432,800 |
| Common Stock Repurchased | N/A | N/A | 0 | 0 | -72,400 |
| Other Financing Activity | -111,000 | -193,000 | -177,000 | -747,000 | -317,800 |
| Financing Cash Flow | $1,443,000 | $-1,353,000 | $-4,963,000 | $-1,963,000 | $13,681,800 |
| Exchange Rate Effect | -4,000 | -26,000 | 41,000 | -54,000 | -30,100 |
| Beginning Cash Position | 723,000 | 797,000 | 542,000 | 597,000 | 322,600 |
| End Cash Position | 3,244,000 | 723,000 | 797,000 | 542,000 | 597,300 |
| Net Cash Flow | $2,525,000 | $-48,000 | $214,000 | $-1,000 | $304,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,501,000 | 1,501,000 | 2,290,000 | 2,087,000 | 2,200,400 |
| Capital Expenditure | -278,000 | -235,000 | -336,000 | -291,000 | -303,300 |
| Free Cash Flow | 1,223,000 | 1,266,000 | 1,954,000 | 1,796,000 | 1,897,100 |